LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 156 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,955,374 | +9.1% | 207,762 | +12.1% | 0.00% | +33.3% |
| Q2 2023 | $12,791,190 | +206.2% | 185,299 | +113.9% | 0.00% | +200.0% |
| Q1 2023 | $4,177,346 | -26.7% | 86,631 | -24.2% | 0.00% | -50.0% |
| Q4 2022 | $5,701,912 | +27.1% | 114,221 | +3.9% | 0.00% | +100.0% |
| Q3 2022 | $4,487,000 | -4.6% | 109,981 | +28.6% | 0.00% | 0.0% |
| Q2 2022 | $4,702,000 | +117.5% | 85,497 | +43.7% | 0.00% | 0.0% |
| Q1 2022 | $2,162,000 | -20.0% | 59,496 | +2.7% | 0.00% | 0.0% |
| Q4 2021 | $2,702,000 | +27.0% | 57,949 | +15.9% | 0.00% | 0.0% |
| Q2 2020 | $2,128,000 | – | 50,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |